Singapore markets close in 5 hours 48 minutes

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
470.41-4.88 (-1.03%)
At close: 04:00PM EDT
470.39 -0.02 (-0.00%)
After hours: 06:28PM EDT

IDEXX Laboratories, Inc.

One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300

IndustryDiagnostics & Research
Full-time employees11,000

Key executives

NameTitlePayExercisedYear born
Mr. Jonathan J. MazelskyPresident, CEO & Director2.77M11.81M1961
Mr. Brian P. McKeonCFO, Executive VP & Treasurer1.4M173.73k1962
Mr. Michael J. LaneExecutive VP and GM of Reference Laboratories & Information Technology1.17M5.67M1969
Mr. John HartSenior Vice President of Global OperationsN/AN/AN/A
Mr. Jeffery D. ChadbourneSenior Vice President of Commercial Finance & Sales OperationsN/AN/A1976
Dr. Martin Smith Ph.D.Executive VP & CTON/AN/A1969
Mr. Ken GradySenior VP & Chief Information OfficerN/AN/AN/A
Ms. Sharon E. UnderbergExecutive VP, General Counsel, & Corporate Secretary881.05k84.31k1961
Mr. Michael P. JohnsonExecutive VP & Chief Human Resources OfficerN/AN/A1978
Mr. George J. FennellSenior VP & Chief Revenue OfficerN/AN/A1969
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Corporate governance

IDEXX Laboratories, Inc.’s ISS governance QualityScore as of 1 July 2024 is 6. The pillar scores are Audit: 6; Board: 2; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.